Skip to main content

HB 917 — Virginia

Compounding pharmacies; use of bulk drug substances, recordkeeping.

Introduced 2027 session House of Delegates

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Board of Pharmacy; compounding pharmacies; use of bulk drug substances; recordkeeping. Establishes additional requirements for when pharmacists may use bulk drug substances in compounding and specifies prohibitions on pharmacist use of (i) bulk drug substances that were withdrawn or removed from the market for reasons of safety and effectiveness or were covered by an investigational new drug application and not approved and (ii) compounded drug products that are essentially a copy of commercially available drug products. The bill permits the Board of Pharmacy to request records of all compounded drug products and requires pharmacists to furnish such records within 48 hours of such request or within a reasonable time as determined by the Board. The bill also permits the Board of Pharmacy to submit any information related to investigations, disciplinary proceedings, or inspection of a licensee to the National Association of Boards of Pharmacy.

Official abstract, as published by the legislature.

  • HB 917 is a bill in the Virginia House of Delegates, 2027 session, introduced January 13, 2026.
  • Sponsored by Rodney T. Willett, with 1 cosponsor.
  • Current status: introduced.
  • Most recent action (July 21, 2026): Continued from last session.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Rodney T. Willett

Cosponsors (1): Elizabeth R. Guzman

History

  1. Introduced, completed
  2. Passed House of Delegates, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House of Delegates Prefiled and ordered printed; Offered 01-14-2026 26105003D Milestone
  2. House of Delegates Referred to Committee on Health and Human Services
  3. House of Delegates Fiscal Impact Statement from Department of Planning and Budget (HB917)
  4. House of Delegates Continued to next session in Health and Human Services (Voice Vote)
  5. House of Delegates Continued from last session Latest

Source: Open States. Last checked November 1, 2026. How we keep this accurate ›